Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 320


A Different Kind of Perioperative Surgical Home: Hospital at Home After Surgery.

Safavi KC, Ricciardi R, Heng M, Eisenhauer EL, Sheer D, Thompson RW, Del Carmen MG.

Ann Surg. 2019 Jul 15. doi: 10.1097/SLA.0000000000003417. [Epub ahead of print] No abstract available.


Mothers' Decisions About Donating Newborns' Blood Spots for Research: A Qualitative Study.

Eisenhauer ER, Tait AR, Kane Low L, Arslanian-Engoren CM.

J Perinat Neonatal Nurs. 2019 May 22. doi: 10.1097/JPN.0000000000000412. [Epub ahead of print]


Ovarian Cancer Surgery - Heed This LION's Roar.

Eisenhauer EL, Chi DS.

N Engl J Med. 2019 Feb 28;380(9):871-873. doi: 10.1056/NEJMe1900044. No abstract available.


A Population-based Study of Survival Impact of New Targeted and Immune-based Therapies for Metastatic or Unresectable Melanoma.

Hanna TP, Nguyen P, Baetz T, Booth CM, Eisenhauer E.

Clin Oncol (R Coll Radiol). 2018 Oct;30(10):609-617. doi: 10.1016/j.clon.2018.05.005. Epub 2018 Jun 28.


Barriers to participation in clinical trials: a physician survey.

Mahmud A, Zalay O, Springer A, Arts K, Eisenhauer E.

Curr Oncol. 2018 Apr;25(2):119-125. doi: 10.3747/co.25.3857. Epub 2018 Apr 30.


Iodate and nitrate transformation by Agrobacterium/Rhizobium related strain DVZ35 isolated from contaminated Hanford groundwater.

Lee BD, Ellis JT, Dodwell A, Eisenhauer EER, Saunders DL, Lee MH.

J Hazard Mater. 2018 May 15;350:19-26. doi: 10.1016/j.jhazmat.2018.02.006. Epub 2018 Feb 6.


Mental health services use by melanoma patients receiving adjuvant interferon: association of pre-treatment mental health care with early discontinuation.

Hanna TP, Baetz T, Xu J, Miao Q, Earle CC, Peng Y, Booth CM, Petrella TM, McKay DR, Nguyen P, Langley H, Eisenhauer E.

Curr Oncol. 2017 Dec;24(6):e503-e512. doi: 10.3747/co.24.3685. Epub 2017 Dec 20.


Real-world evidence in the treatment of ovarian cancer.

Eisenhauer EA.

Ann Oncol. 2017 Nov 1;28(suppl_8):viii61-viii65. doi: 10.1093/annonc/mdx443. Review.


OV21/PETROC: a randomized Gynecologic Cancer Intergroup phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer.

Provencher DM, Gallagher CJ, Parulekar WR, Ledermann JA, Armstrong DK, Brundage M, Gourley C, Romero I, Gonzalez-Martin A, Feeney M, Bessette P, Hall M, Weberpals JI, Hall G, Lau SK, Gauthier P, Fung-Kee-Fung M, Eisenhauer EA, Winch C, Tu D, MacKay HJ.

Ann Oncol. 2018 Feb 1;29(2):431-438. doi: 10.1093/annonc/mdx754.


Impact of tumour histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group Study.

Seamon LG, Java JJ, Monk BJ, Penson RT, Brown J, Mannel RS, Oaknin A, Leitao MM, Eisenhauer EL, Long HJ, Liao SY, Tewari KS.

Br J Cancer. 2018 Jan;118(2):162-170. doi: 10.1038/bjc.2017.400. Epub 2017 Nov 28.


Participants' Understanding of Informed Consent for Biobanking: A Systematic Review.

Eisenhauer ER, Tait AR, Rieh SY, Arslanian-Engoren CM.

Clin Nurs Res. 2019 Jan;28(1):30-51. doi: 10.1177/1054773817722690. Epub 2017 Jul 26.


Multigene expression profile testing in breast cancer: is there a role for family physicians?

O'Brien MA, Carroll JC, Manca DP, Miedema B, Groome PA, Makuwaza T, Easley J, Sopcak N, Jiang L, Decker K, McBride ML, Moineddin R, Permaul JA, Heisey R, Eisenhauer EA, Krzyzanowska MK, Pruthi S, Sawka C, Schneider N, Sussman J, Urquhart R, Versaevel C, Grunfeld E; Canadian Team to Improve Community-Based Cancer Care Along the Continuum.

Curr Oncol. 2017 Apr;24(2):95-102. doi: 10.3747/co.24.3457. Epub 2017 Apr 27.


A phase-I study of lapatinib in combination with foretinib, a c-MET, AXL and vascular endothelial growth factor receptor inhibitor, in human epidermal growth factor receptor 2 (HER-2)-positive metastatic breast cancer.

Chia SK, Ellard SL, Mates M, Welch S, Mihalcioiu C, Miller WH Jr, Gelmon K, Lohrisch C, Kumar V, Taylor S, Hagerman L, Goodwin R, Wang T, Sakashita S, Tsao MS, Eisenhauer E, Bradbury P.

Breast Cancer Res. 2017 May 2;19(1):54. doi: 10.1186/s13058-017-0836-3.


Early integration of palliative care into standard oncology care: evidence and overcoming barriers to implementation.

Kain DA, Eisenhauer EA.

Curr Oncol. 2016 Dec;23(6):374-377. doi: 10.3747/co.23.3404. Epub 2016 Dec 21. No abstract available.


Reproductive counseling, contraception, and unplanned pregnancy in fertile women treated by gynecologic oncologists.

Crafton SM, Lynch CD, Cohn DE, Eisenhauer EL.

Gynecol Oncol Rep. 2016 Nov 24;19:22-26. doi: 10.1016/j.gore.2016.11.006. eCollection 2017 Feb.


Primary care providers' experiences with and perceptions of personalized genomic medicine.

Carroll JC, Makuwaza T, Manca DP, Sopcak N, Permaul JA, O'Brien MA, Heisey R, Eisenhauer EA, Easley J, Krzyzanowska MK, Miedema B, Pruthi S, Sawka C, Schneider N, Sussman J, Urquhart R, Versaevel C, Grunfeld E.

Can Fam Physician. 2016 Oct;62(10):e626-e635.


Religious Values and Biobanking Decisions: An Integrative Review.

Eisenhauer ER, Arslanian-Engoren C.

Res Theory Nurs Pract. 2016;30(2):104-23. Review.


Utility of PET-CT to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer: Results of ACRIN6671/GOG0233 trial.

Atri M, Zhang Z, Dehdashti F, Lee SI, Ali S, Marques H, Koh WJ, Moore K, Landrum L, Kim JW, DiSilvestro P, Eisenhauer E, Schnell F, Gold M.

Gynecol Oncol. 2016 Sep;142(3):413-9. doi: 10.1016/j.ygyno.2016.05.002. Epub 2016 Jul 27.


Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer.

Rayson D, Lupichuk S, Potvin K, Dent S, Shenkier T, Dhesy-Thind S, Ellard SL, Prady C, Salim M, Farmer P, Allo G, Tsao MS, Allan A, Ludkovski O, Bonomi M, Tu D, Hagerman L, Goodwin R, Eisenhauer E, Bradbury P.

Breast Cancer Res Treat. 2016 May;157(1):109-16. doi: 10.1007/s10549-016-3812-1. Epub 2016 Apr 26.


A pilot study of topical imiquimod therapy for the treatment of recurrent extramammary Paget's disease.

Cowan RA, Black DR, Hoang LN, Park KJ, Soslow RA, Backes FJ, Gardner GJ, Abu-Rustum NR, Leitao MM Jr, Eisenhauer EL, Chi DS.

Gynecol Oncol. 2016 Jul;142(1):139-143. doi: 10.1016/j.ygyno.2016.04.028. Epub 2016 May 5.


Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial.

Ledermann JA, Embleton AC, Raja F, Perren TJ, Jayson GC, Rustin GJS, Kaye SB, Hirte H, Eisenhauer E, Vaughan M, Friedlander M, González-Martín A, Stark D, Clark E, Farrelly L, Swart AM, Cook A, Kaplan RS, Parmar MKB; ICON6 collaborators.

Lancet. 2016 Mar 12;387(10023):1066-1074. doi: 10.1016/S0140-6736(15)01167-8. Erratum in: Lancet. 2016 Apr 23;387(10029):1722.


Prognostic and predictive effects of diabetes, hypertension, and coronary artery disease among women on extended adjuvant letrozole: NCIC CTG MA.17.

Goodwin RA, Jamal R, Booth CM, Goss PE, Eisenhauer EA, Tu D, Shepherd LE.

Eur J Cancer. 2016 May;58:97-103. doi: 10.1016/j.ejca.2016.01.014. Epub 2016 Mar 14.


A Prospective, Comparative Study for the Evaluation of Postoperative Pain and Quality of Recovery in Patients Undergoing Robotic Versus Open Hysterectomy for Staging of Endometrial Cancer.

Cohn DE, Castellon-Larios K, Huffman L, Salani R, Fowler JM, Copeland LJ, O'Malley DM, Backes FJ, Eisenhauer EL, Abdel-Rasoul M, Puente EG, Bergese SD.

J Minim Invasive Gynecol. 2016 Mar-Apr;23(3):429-34. doi: 10.1016/j.jmig.2016.01.002. Epub 2016 Jan 8.


First application of the Automated QUantitative Analysis (AQUA) technique to quantify PTEN protein expression in ovarian cancer: A correlative study of NCIC CTG OV.16.

Weberpals JI, Amin MS, Chen BE, Tu D, Spaans JN, Squire JA, Eisenhauer EA, Virk S, Ma D, Duciaume M, Hoskins P, LeBrun DP.

Gynecol Oncol. 2016 Mar;140(3):486-93. doi: 10.1016/j.ygyno.2016.01.015. Epub 2016 Jan 13.


Documentation of Pregnancy Risk Assessment and Pregnancy Among Women Presenting for Gynecologic Oncology Consultation.

Crafton S, Nekkanti S, Lynch C, Cohn DE, Fowler JM, Copeland LJ, O'Malley DM, Salani R, Backes FJ, Eisenhauer EL.

Int J Gynecol Cancer. 2016 Jan;26(1):35-42. doi: 10.1097/IGC.0000000000000576.


Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma: An NRG Oncology/Gynecologic Oncology Group Study.

Eskander RN, Ali S, Dellinger T, Lankes HA, Randall LM, Ramirez NC, Monk BJ, Walker JL, Eisenhauer E, Hoang BH.

Int J Gynecol Cancer. 2016 Jan;26(1):125-32. doi: 10.1097/IGC.0000000000000563.


Randomized study of sequential cisplatin-topotecan/carboplatin-paclitaxel versus carboplatin-paclitaxel: effects on quality of life.

Brotto L, Brundage M, Hoskins P, Vergote I, Cervantes A, Casado HA, Poveda A, Eisenhauer E, Tu D; Gynecologic Cancer Intergroup Study of NCIC Clinical Trials Group (NCIC CTG); European Organization for Research and Treatment of Cancer - Gynecologic Cancer Group (EORTC-GCG); Grupo de Investigación de Cáncer de Ovario (GEICO).

Support Care Cancer. 2016 Mar;24(3):1241-9. doi: 10.1007/s00520-015-2873-8. Epub 2015 Aug 25.


Informed Consent and the Use of Biospecimens in Research.

Eisenhauer ER.

Am J Nurs. 2015 Jul;115(7):11. doi: 10.1097/01.NAJ.0000467253.32265.28. No abstract available.


Emerging therapies: angiogenesis inhibitors for ovarian cancer.

Jackson AL, Eisenhauer EL, Herzog TJ.

Expert Opin Emerg Drugs. 2015 Jun;20(2):331-46. doi: 10.1517/14728214.2015.1036739. Review.


A phase II study of the HDAC inhibitor SB939 in patients with castration resistant prostate cancer: NCIC clinical trials group study IND195.

Eigl BJ, North S, Winquist E, Finch D, Wood L, Sridhar SS, Powers J, Good J, Sharma M, Squire JA, Bazov J, Jamaspishvili T, Cox ME, Bradbury PA, Eisenhauer EA, Chi KN.

Invest New Drugs. 2015 Aug;33(4):969-76. doi: 10.1007/s10637-015-0252-4. Epub 2015 May 19.


An interview with Dr Barbara A. Carper.

Eisenhauer ER.

ANS Adv Nurs Sci. 2015 Apr-Jun;38(2):73-82. doi: 10.1097/ANS.0000000000000067.


A phase II study of SB939, a novel pan-histone deacetylase inhibitor, in patients with translocation-associated recurrent/metastatic sarcomas-NCIC-CTG IND 200†.

Chu QS, Nielsen TO, Alcindor T, Gupta A, Endo M, Goytain A, Xu H, Verma S, Tozer R, Knowling M, Bramwell VB, Powers J, Seymour LK, Eisenhauer EA.

Ann Oncol. 2015 May;26(5):973-81. doi: 10.1093/annonc/mdv033. Epub 2015 Jan 28.


Phase II study of PX-866 in recurrent glioblastoma.

Pitz MW, Eisenhauer EA, MacNeil MV, Thiessen B, Easaw JC, Macdonald DR, Eisenstat DD, Kakumanu AS, Salim M, Chalchal H, Squire J, Tsao MS, Kamel-Reid S, Banerji S, Tu D, Powers J, Hausman DF, Mason WP.

Neuro Oncol. 2015 Sep;17(9):1270-4. doi: 10.1093/neuonc/nou365. Epub 2015 Jan 20.


Predicting inpatient stay lasting 2 midnights or longer after robotic surgery for endometrial cancer.

Liang MI, Rosen MA, Rath KS, Hade EM, Clements AE, Backes FJ, Eisenhauer EL, Salani R, O'Malley DM, Fowler JM, Cohn DE.

J Minim Invasive Gynecol. 2015 May-Jun;22(4):583-9. doi: 10.1016/j.jmig.2014.12.167. Epub 2015 Jan 5.


Phase II study of oral ridaforolimus in women with recurrent or metastatic endometrial cancer.

Tsoref D, Welch S, Lau S, Biagi J, Tonkin K, Martin LA, Ellard S, Ghatage P, Elit L, Mackay HJ, Allo G, Tsao MS, Kamel-Reid S, Eisenhauer EA, Oza AM.

Gynecol Oncol. 2014 Nov;135(2):184-9. doi: 10.1016/j.ygyno.2014.06.033. Epub 2014 Aug 28.


Hereditary cancer syndromes with high risk of endometrial and ovarian cancer: surgical options for personalized care.

McCann GA, Eisenhauer EL.

J Surg Oncol. 2015 Jan;111(1):118-24. doi: 10.1002/jso.23743. Epub 2014 Aug 20. Review.


Letter to the editor.

Eisenhauer E.

ANS Adv Nurs Sci. 2014 Jul-Sep;37(3):190-1. doi: 10.1097/ANS.0000000000000042. No abstract available.


Does intra-operative radiation at the time of pelvic exenteration improve survival for patients with recurrent, previously irradiated cervical, vaginal, or vulvar cancer?

Backes FJ, Billingsley CC, Martin DD, Tierney BJ, Eisenhauer EL, Cohn DE, O'Malley DM, Salani R, Copeland LJ, Fowler JM.

Gynecol Oncol. 2014 Oct;135(1):95-9. doi: 10.1016/j.ygyno.2014.07.093. Epub 2014 Jul 30.


Progression-free survival as an end-point in solid tumours--perspectives from clinical trials and clinical practice.

Robinson AG, Booth CM, Eisenhauer EA.

Eur J Cancer. 2014 Sep;50(13):2303-8. doi: 10.1016/j.ejca.2014.05.024. Epub 2014 Jun 25. Review.


Disease-free survival as an end-point in the treatment of solid tumours--perspectives from clinical trials and clinical practice.

Robinson AG, Booth CM, Eisenhauer EA.

Eur J Cancer. 2014 Sep;50(13):2298-302. doi: 10.1016/j.ejca.2014.05.016. Epub 2014 Jun 12. Review.


A phase II study of gemcitabine, carboplatin and bevacizumab for the treatment of platinum-sensitive recurrent ovarian cancer.

Eisenhauer EL, Zanagnolo V, Cohn DE, Salani R, O'Malley DM, Sutton G, Callahan MJ, Cobb B, Fowler JM, Copeland LJ.

Gynecol Oncol. 2014 Aug;134(2):262-6. doi: 10.1016/j.ygyno.2014.05.030. Epub 2014 Jun 5.


Feasibility of interval cytoreduction following neoadjuvant chemotherapy with carboplatin, weekly paclitaxel, and bevacizumab for advanced ovarian cancer--a phase 1 study.

Salani R, O'Malley DM, Copeland LJ, Cohn DE, Backes FJ, Fowler JM, Eisenhauer EL.

Int J Gynecol Cancer. 2014 May;24(4):682-6. doi: 10.1097/IGC.0000000000000107.


Postoperative outcomes among patients undergoing thoracostomy tube placement at time of diaphragm peritonectomy or resection during primary cytoreductive surgery for ovarian cancer.

Sandadi S, Long K, Andikyan V, Vernon J, Zivanovic O, Eisenhauer EL, Levine DA, Sonoda Y, Barakat RR, Chi DS.

Gynecol Oncol. 2014 Feb;132(2):299-302. doi: 10.1016/j.ygyno.2013.11.026. Epub 2013 Dec 1.


DNA damage-binding complex recruits HDAC1 to repress Bcl-2 transcription in human ovarian cancer cells.

Zhao R, Han C, Eisenhauer E, Kroger J, Zhao W, Yu J, Selvendiran K, Liu X, Wani AA, Wang QE.

Mol Cancer Res. 2014 Mar;12(3):370-80. doi: 10.1158/1541-7786.MCR-13-0281. Epub 2013 Nov 18.


Molecular determinants of outcome with mammalian target of rapamycin inhibition in endometrial cancer.

Mackay HJ, Eisenhauer EA, Kamel-Reid S, Tsao M, Clarke B, Karakasis K, Werner HM, Trovik J, Akslen LA, Salvesen HB, Tu D, Oza AM.

Cancer. 2014 Feb 15;120(4):603-10. doi: 10.1002/cncr.28414. Epub 2013 Oct 25.


Reducing readmissions after robotic surgical management of endometrial cancer: a potential for improved quality care.

Liang MI, Rosen MA, Rath KS, Clements AE, Backes FJ, Eisenhauer EL, Salani R, O'Malley DM, Fowler JM, Cohn DE.

Gynecol Oncol. 2013 Dec;131(3):508-11. doi: 10.1016/j.ygyno.2013.09.033. Epub 2013 Oct 4.


Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma?

Ricci S, Giuntoli RL 2nd, Eisenhauer E, Lopez MA, Krill L, Tanner EJ 3rd, Gehrig PA, Havrilesky LJ, Secord AA, Levinson K, Frasure H, Celano P, Fader AN.

Gynecol Oncol. 2013 Dec;131(3):629-33. doi: 10.1016/j.ygyno.2013.08.037. Epub 2013 Sep 7.


Clinical and toxicity predictors of response and progression to temsirolimus in women with recurrent or metastatic endometrial cancer.

Goodwin RA, Jamal R, Tu D, Walsh W, Dancey J, Oza AM, Elit L, Eisenhauer EA.

Gynecol Oncol. 2013 Nov;131(2):315-20. doi: 10.1016/j.ygyno.2013.08.004. Epub 2013 Aug 9.


A phase I study of histone deacetylase inhibitor, pracinostat (SB939), in pediatric patients with refractory solid tumors: IND203 a trial of the NCIC IND program/C17 pediatric phase I consortium.

Zorzi AP, Bernstein M, Samson Y, Wall DA, Desai S, Nicksy D, Wainman N, Eisenhauer E, Baruchel S.

Pediatr Blood Cancer. 2013 Nov;60(11):1868-74. doi: 10.1002/pbc.24694. Epub 2013 Jul 25.


Phase II study of temsirolimus (CCI-779) in women with recurrent, unresectable, locally advanced or metastatic carcinoma of the cervix. A trial of the NCIC Clinical Trials Group (NCIC CTG IND 199).

Tinker AV, Ellard S, Welch S, Moens F, Allo G, Tsao MS, Squire J, Tu D, Eisenhauer EA, MacKay H.

Gynecol Oncol. 2013 Aug;130(2):269-74. doi: 10.1016/j.ygyno.2013.05.008. Epub 2013 May 11.


Supplemental Content

Loading ...
Support Center